Literature DB >> 5563349

An analysis of the University Group Diabetes Study Program: data results and conslusions.

B Leibel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5563349      PMCID： PMC1931116     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials.

Authors:  James J Schlesselman
Journal:  J R Soc Med       Date:  2016-01       Impact factor: 5.344

2.  Diabetic hearts and biguanides.

Authors:  P Biron
Journal:  Can Med Assoc J       Date:  1975-08-09       Impact factor: 8.262

Review 3.  Observational research--opportunities and limitations.

Authors:  Edward J Boyko
Journal:  J Diabetes Complications       Date:  2013-09-19       Impact factor: 2.852

Review 4.  Beneficial and detrimental effects of glycemic control on cardiovascular disease in type 2 diabetes.

Authors:  Pam R Taub; Erin Higginbotham; Robert R Henry
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

5.  Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.

Authors:  Peter D Reaven; Thomas E Moritz; Dawn C Schwenke; Robert J Anderson; Michael Criqui; Robert Detrano; Nicholas Emanuele; Moti Kayshap; Jennifer Marks; Sunder Mudaliar; R Harsha Rao; Jayendra H Shah; Steven Goldman; Domenic J Reda; Madeline McCarren; Carlos Abraira; William Duckworth
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

Review 6.  Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS.

Authors:  Samit Ghosal; Binayak Sinha
Journal:  J Diabetes Res       Date:  2015-11-15       Impact factor: 4.011
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.